Trials / Completed
CompletedNCT01262040
Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally Invasive
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 154 (actual)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether narrowband imaging (NBI) makes it easier for a surgeon to see cancer. NBI is a kind of light. Normally, white light is used during surgery. White light uses many wavelengths of light. NBI only uses two wavelengths which highlight the blood vessels. This makes it easier for the surgeon to see blood vessels. Tumors often have more blood vessels than normal tissue. As a result, NBI may make it easier for the surgeon to see small tumors. In this study the surgeon will look with both normal white light and NBI. This way a comparison can be made to determine which is superior. Improved identification of tumors allows doctors and patients to make informed decisions about whether treatment is needed after surgery. It also provides additional information to determine which treatments may be best.
Conditions
- Endometrial Cancer
- Fallopian Tube Cancer
- Ovarian Cancer
- Peritoneal Cancer
- Gastrointestinal Carcinoma
- Pancreatic Carcinoma
- Lung Cancer
- Esophageal Carcinoma
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Narrow Band Imaging (NBI) | The intervention is visual assessment of the peritoneal or pleural surface with NBI followed by biopsy and photographic documentation of any abnormal lesions. Photograph or video of abnormality(ies) under white light and NBI. |
Timeline
- Start date
- 2010-12-14
- Primary completion
- 2018-10-29
- Completion
- 2018-10-29
- First posted
- 2010-12-17
- Last updated
- 2018-11-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01262040. Inclusion in this directory is not an endorsement.